Newsbenzinga
Ligand Pharmaceuticals Q3 2026 Earnings Call Transcript
· Published
Article summary
Ligand Pharmaceuticals (NASDAQ:LGND) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by
An excerpt from the original article.
Comments —
Loading comments…